Global Development of Anticancer Therapies for Rare Cancers, Pediatric Cancers, and Molecular Subtypes of Common Cancers
Advances in genetic sequencing and other diagnostic technologies have enabled the use of precision medicine in clinical cancer care, as well as the development of novel therapies that are targeted to specific molecular drivers of cancer. Developing these new agents and making them accessible to pati...
Main Authors: | H. Kim Lyerly, Jun Ren, Renzo Canetta, Gi Hyun Kim, Sumimasa Nagai, Tomohiro Yamaguchi, Ken Hatogai, Hiroshi Katayama, Silvy Da Rocha Dias, Daniel McManus, Kathy Soltys, Zhimin Yang, Olufumilayo Olopade, Nancy Goodman, Greg Reaman, Thomas Gross |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society of Clinical Oncology
2018-12-01
|
Series: | Journal of Global Oncology |
Online Access: | http://ascopubs.org/doi/10.1200/JGO.18.00092 |
Similar Items
-
Flexible and Expedited Regulatory Review Processes for Innovative Medicines and Regenerative Medical Products in the US, the EU, and Japan
by: Sumimasa Nagai
Published: (2019-08-01) -
Echinococcus granulosus: Cure for Cancer Revisited
by: Shiwanthi L. Ranasinghe, et al.
Published: (2018-03-01) -
Evaluating the number of stages in development of squamous cell and adenocarcinomas across cancer sites using human population-based cancer modeling.
by: Julia Kravchenko, et al.
Published: (2012-01-01) -
Chromosome Instability; Implications in Cancer Development, Progression, and Clinical Outcomes
by: Raghvendra Vishwakarma, et al.
Published: (2020-03-01) -
Assessing perceptions of genetic risk and breast cancer of women diagnosed and undiagnosed with breast cancer in Ibadan, Nigeria
by: Jasmine Solola, et al.
Published: (2016-08-01)